222 related articles for article (PubMed ID: 6148718)
1. Tardive dyskinesia: current clinical issues.
Burke RE
Neurology; 1984 Oct; 34(10):1348-53. PubMed ID: 6148718
[TBL] [Abstract][Full Text] [Related]
2. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
Seigneurie AS; Sauvanaud F; Limosin F
Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
[TBL] [Abstract][Full Text] [Related]
3. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
van Harten PN; Hoek HW; Matroos GE; van Os J
J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological mechanisms underlying tardive dyskinesia.
Gerlach J
Psychopharmacology Suppl; 1985; 2():98-103. PubMed ID: 2860666
[TBL] [Abstract][Full Text] [Related]
5. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
[TBL] [Abstract][Full Text] [Related]
6. The natural history of tardive dyskinesia.
Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
[TBL] [Abstract][Full Text] [Related]
7. A potential mechanism underlying the voluntary suppression of tardive dyskinesia.
Caligiuri MP; Lohr JB
J Psychiatr Res; 1989; 23(3-4):257-66. PubMed ID: 2576826
[TBL] [Abstract][Full Text] [Related]
8. Managing antipsychotic-induced tardive dyskinesia.
Gardos G
Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
[TBL] [Abstract][Full Text] [Related]
9. Current topics in tardive dyskinesia in Japan.
Inada T; Yagi G
Psychiatry Clin Neurosci; 1995 Dec; 49(5-6):239-44. PubMed ID: 8726107
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia, clozapine, and treatment response.
Dalack GW; Becks L; Meador-Woodruff JH
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):567-73. PubMed ID: 9682273
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management.
Salem H; Pigott T; Zhang XY; Zeni CP; Teixeira AL
Expert Rev Neurother; 2017 Sep; 17(9):883-894. PubMed ID: 28750568
[TBL] [Abstract][Full Text] [Related]
12. Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials.
Lockwood JT; Remington G
Expert Opin Emerg Drugs; 2015 Sep; 20(3):407-21. PubMed ID: 26166007
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam in tardive dyskinesia.
Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
[TBL] [Abstract][Full Text] [Related]
14. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
[TBL] [Abstract][Full Text] [Related]
15. Incidence of tardive dyskinesia in older adult patients treated with olanzapine or conventional antipsychotics.
Kinon BJ; Kollack-Walker S; Jeste D; Gupta S; Chen L; Case M; Chen J; Stauffer V
J Geriatr Psychiatry Neurol; 2015 Mar; 28(1):67-79. PubMed ID: 25009161
[TBL] [Abstract][Full Text] [Related]
16. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis.
Trugman JM; Leadbetter R; Zalis ME; Burgdorf RO; Wooten GF
Mov Disord; 1994 Jul; 9(4):441-6. PubMed ID: 7969212
[TBL] [Abstract][Full Text] [Related]
17. Buspirone in the treatment of tardive dyskinesia.
Moss LE; Neppe VM; Drevets WC
J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
[TBL] [Abstract][Full Text] [Related]
18. Tardive dyskinesia: a review and current treatment options.
Najib J
Am J Ther; 1999 Jan; 6(1):51-60. PubMed ID: 10423647
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal study of correlations among tardive dyskinesia, drug-induced parkinsonism, and psychosis.
Hansen TE; Weigel RM; Brown WL; Hoffman WF; Casey DE
J Neuropsychiatry Clin Neurosci; 1992; 4(1):29-35. PubMed ID: 1352714
[TBL] [Abstract][Full Text] [Related]
20. [Tiapride in the treatment of irreversible tardive dyskinesia--initial experiences].
Leblhuber F; Reisecker F; Bengesser G
Z Gerontol; 1987; 20(1):49-51. PubMed ID: 2883781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
